Hikal inks pact with Pfizer for supplying APIs

Hikal Ltd. has completed a contract manufacturing agreement for supply of active pharmaceutical ingredients (API's) with Pfizer Inc., a global leader in Pharmaceuticals. Terms of the agreement were not disclosed.

"We are extremely pleased to be selected as a long term contract manufacturer by Pfizer", said Jai Hiremath, vice chairman & managing director of Hikal Ltd. "This agreement will have a substantial impact on our Pharmaceutical business in the coming years".

"We look forward to working with Hikal, a respected contract manufacturing company and are delighted that they are able to contribute towards supply of APIs for Pfizer products", said Peter Stevenson, vice-president, global contract manufacturing, procurement and Pfizer Centre Source, Pfizer Inc.

Hikal is a reliable long-term outsourcing partner to companies in the pharmaceuticals, agrochemicals and specialty chemicals industry. The company has been supplying key APIs and intermediates, manufactured using stringent global quality standards, for it's customers in the United States, Europe and Japan.

Hikal's advanced manufacturing facilities have been inspected and approved by globally recognized bodies such as the US FDA. The API and pharmaceutical intermediates manufacturing facilities are situated in Jigani (Bangalore) and Panoli (Gujarat) respectively. The crop protection facilities are located at Taloja and Mahad (Maharashtra). Hikal's manufacturing activities are supported by state-of-the-art research centres and pilot plant facilities located at Bangalore and Taloja respectively.